Kathleen Gallagher
ORCID: 0000-0002-6952-7885Also affiliated with Harvard University, Massachusetts General Hospital, Center for Cancer Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 12 papers. Top paper: “Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial”.
Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more
Eric D. Laing, Jarina Pena DaMata, Katherine Pohida, Marana S Tso, E Samuels +94 more
Stephanie A Richard, Eric D. Laing, Anthony C Fries, Eugene V. Millar, Mark P. Simons +83 more
Kathleen Gallagher, Yi‐Bin Chen, Mark B. Leick, Steven L. McAfee, Areej El‐Jawahri +11 more
Stephanie A Richard, David A Lindholm, Katrin Mende, Anuradha Ganesan, Nikhil Huprikar +85 more
Dakota Archambault, Jeffrey Randall, Adam Shepro, Lauren E. Styskal, David R. Glenn +6 more
Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Yam +2 more
Mark B. Leick, Katie Maurer, Satyen H. Gohil, Rebecca C. Larson, Ning Yao +22 more
Myrna Charles, Christopher S. Murrill, Olga L. Henao, Kathleen Gallagher, Amen Ben Hamida
Michael C. Kann, Charlotte Graham, Christopher Mount, Ana P. Castaño, Won‐Ho Lee +10 more
Susan Klaeger, Siranush Sarkizova, Leah R. Pearlman, Da‐Yuan Chen, Kathleen Gallagher +53 more
Trisha R. Berger, Michael C. Kann, Harrison Silva, Rebecca C. Larson, Mark B. Leick +8 more